Derek Abbott
@inflammgenetics
Physician Scientist target hunting in inflammation. Views are my own.
ID: 1410964974
07-05-2013 19:03:40
976 Tweet
492 Followers
171 Following
The phase I multiple ascending dose RIPK2 inhibitor trial is done! OPM-101 continues to show an excellent profile! #ripk2 Oncodesign SA oncodesign.com/fr/opm-annonce…
